Skip to main content

Table 4 Ipsilateral tumor recurrence rate stratified by age in this cohort study and EORTC study

From: The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation

 

This cohort study

EORTC study

Age, years

All

n = 419

1993–2003

n = 163

2003–2010

n = 256

No boost

Boost

Median f/u

9.3 y

14.4y

7.9y

10.8y

10y IBTR rate

8y IBTR rate

10y IBTR rate

 ≤ 40

17.1%

25.4%

4.0%

34.9%

13.5%

 41–50

3.7%

6.2%

0.0%

12.5%

8.7%

 51–60

2.4%

2.0%

2.8%

7.8%

4.9%

 ≥ 61

1.6%

0.0%

2.3%

7.3%

3.8%

 Total

4.0%

5.5%

2.2%

10.2%

6.2%

  1. Abbreviations: EORTC European organisation for research and treatment of cancer, f/u Follow up time, y Years